Taking traditional knowledge to the market by Bode, M.
I I A S  N E W S L E T T E R  # 4 5   A U T U M N  2 0 0 7 2 3
R E S E A R C H
Looking at Asian medical traditions through the lens of medicines and manufacturers
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In February 2002 the Arya Vaidya Sala, a manufacturer of Ayurvedic medicines, 
celebrated its centenary. On this occasion 
the provincial town of Kottakkal, situated 
in the hills of Kerala a few hours drive from 
the coastal city of Calicut (Kozhikode), 
was flooded with three thousand invitees. 
Among them were key figures from the 
Ayurvedic world such as Devendra Trigu-
na, the chairman of the All India Ayurvedic 
Congress, and Ashok Vaidya, a renowned 
pharmacologist by training, scientific advi-
sor to a large Ayurvedic company, and 
head of the Mumbai branch of the Centre 
for Indian World Culture. The Union Min-
ister of Health and Family Welfare, C.P. 
Thakur, and M. M. Joshi, the Union Min-
ister of Science, Technology and Human 
Resource Management added lustre to the 
occasion. People were honoured for their 
achievements in the field of Ayurveda and 
the gathering certainly had a national ring 
to it. In between the speeches and the dis-
tribution of awards to people who had pro-
vided ‘service to Ayurveda’, Indian classical 
music was played. Many of those present 
had travelled hundreds or even thousands 
of miles to celebrate that exactly one hun-
dred years previously P.S. Varier had started 
the industrial production of Ayurvedic for-
mulas in a small building that still stands 
on the premises of one of the factories of 
the company. 
The size of the Arya Vaidya Sala does not 
justify the fact that its centenary was cel-
ebrated as a national event. With a turnover 
of US$16 million and 600 employees the 
firm is relatively small. At stake though, was 
the status of Ayurveda and the construction 
of a national Indian identity that includes 
both tradition and modernity. In many 
speeches the superiority of Indian medicine 
and culture was juxtaposed with Western 
medical materialism and commercialism. 
P.S. Varier, the founder of the Arya Vaidya 
Sala, was presented as a cultural hero. Var-
ier was a medical broker and a moderniser 
of tradition. Trained in both Ayurveda and 
Western medicine he freely made use of 
modern technology and the modern medi-
cal insights of his times. When he began the 
production of Ayurvedic medicines at the 
beginning of the 20th century, Varier had 
to deal with criticism from the Ayurvedic 
authorities of his time who opposed the 
industrial production of Ayurvedic for-
mulas on epistemological and technical 
grounds. These Ayurvedic purists argued 
that standardisation of medicines contra-
dicts the individual approach of Ayurveda 
and that the use of modern production and 
preservation techniques violates what has 
been written in the Ayurvedic canons. In 
short, according to these pandits (cultural 
authorities) the large scale production of 
indigenous medicines, the standardisation 
it involves, and the need for conserving 
the medicines to extend their shelf life, is 
an unwanted diversion from the tenets of 
Ayurveda.1   
Medicines and identity
In many of the speeches given at the cen-
tenary, Ayurveda was presented as the 
antipode of Western medicine. This Indian 
medical tradition was contrasted with its 
Western counterpart frequently criticised 
for its ‘unbridled commercialism’ and side-
effects. “One man’s illness should not be 
another man’s celebration” was how one 
of the keynote speakers at the centenary 
expressed this to me in an interview I had 
with him in 1996. Repeatedly high consul-
tation fees and unnecessary use of expen-
sive diagnostic tests are given as proof of 
the assumed money mindedness of West-
ern medicine. According to the Ayurvedic 
practitioners and managers working for 
Ayurvedic manufacturers that I interviewed, 
Western medical treatment is like “shov-
elling dust under the carpet”  and can be 
compared to “printing money in times of 
inflation, an activity that makes the prob-
lem worse.” In contrast, vaidyas (Ayurvedic 
physicians) are represented as redeemers 
of physical and mental suffering. Western 
medicine and science are seen as exploit-
ive, while Indian knowledge traditions such 
as Ayurveda are said to advance somatic, 
social, psychological and spiritual well-
being. Ayurveda is associated with the non-
violence ascribed to the Buddhist emperor 
Asoka - under whom India was united for 
the first time in the 1st century B.C. - and 
M. K. Gandhi, the father of the nation. 
In India, Western medicine is linked to 
exploitation and material gain at the expense 
of health and well being of the society and 
its individuals. Other oppositions that are 
used to describe Western versus Indian 
medicine are nature’s exploitation versus 
ecological awareness, outside versus inside, 
and materialism versus spirituality. Indeed, 
India’s medical traditions share in the good, 
truth and beauty ascribed to tradition.
The commodification of  
Asian medicine
I visited the Arya Vaidya Sala, along with 
other large Ayurvedic and Unani manu-
facturers in India, during the period from 
1996 to 2002. I analysed Indian medicine 
as a commercial activity and looked at two 
Indian medical traditions - Ayurveda and 
Unani Tibb - through the lens of the Indian 
indigenous medical industry and its prod-
ucts.2 My main interest was in the ways the 
logic of the market has shaped, constrained 
and transformed Ayurvedic and Unani Tibb. 
I discovered that nowadays approximately 
90% of the Ayurvedic and Unani formulas 
produced are over-the-counter brands that 
are marketed to urban middle class con-
sumers. I analysed the advertisements and 
promotional materials of the manufacturers 
under investigation and spoke extensively to 
their marketing personnel. Three marketing 
themes emerged from this exercise: tradi-
tion, modernity and nature. Ayurvedic and 
Unani medicines are sold as curative and 
promotive natural remedies that are both 
modern and traditional at the same time. 
These substances are linked to the hey-
days of Indian civilisation and a humane 
approach to medicine. At the same time 
large Ayurvedic and Unani manufacturers 
use modern science and technology to cre-
ate a competitive edge and distance them-
selves from the image of backwardness that 
also clings to Indian medical traditions. 
Modern pharmacological research data is 
used to promote the quality and effectivity 
of their products. This does not undermine 
the ‘Indianness’ of their medicines, because 
manufacturers denied the epistemological 
differences between biomedicine and Indian 
medicine and ignored the fact that modern 
pharmacology has its origin in Europe. 3 
The study of medicines and its manufac-
turers has a lot to offer to social-cultural 
studies of Asian medical traditions such 
as Ayurveda, Traditional Chinese Medicine, 
Tibetan Medicine, to mention the ones 
that are best known in the West. As I have 
illustrated, medicines can be vehicles of 
ideology and identity construction. In other 
social contexts medicines perform different 
functions. For example, in the consultation 
room of a physician, medicines facilitate 
and steer the professional transformation of 
non-well-being into a disease entity, which 
in turn suggests treatment. In the context 
of the family, however, buying a medicine 
for a relative can emit a message of love 
and care. In the modern laboratory Indian 
medicines are expected to generate proof 
of their efficacy in terms of contemporary 
pharmacological explanatory models. With-
in a religious and traditional framework 
Ayurvedic and Unani medicines are seen as 
gifts of the rishis (seers) or tabibs (Muslim 
scholars) to ailing humanity and it is said 
that their medical effect is enhanced by the 
superior moral status of their designers and 
dispensers. Finally, on the price lists of man-
ufacturers, Ayurvedic and Unani medicines 
have become objects of trade and earners 
of profit.
Pharmaceutical anthropology as 
analytic framework
Considering the prominence of therapeutic 
drugs for the practice and image of contem-
porary Asian medical traditions, one won-
ders why anthropologists and social histo-
rians working on Asian medical traditions 
have largely ignored medical substances. A 
bias towards notions and ideas, as well as 
fear of the theoretical and technical aspects 
of drug designing and manufacturing, 
might have deterred them from the study 
of medical substances. This is a pity as for 
almost 20 years there has been an analytic 
framework for investigating the social-cul-
tural aspects of medicines. The first anthro-
pological volume that made medicines its 
central object of study appeared in 1988 
under the title The Context of Medicines in 
Developing Countries: Studies in Pharmaceu-
tical Anthropology.4 Medicines, the authors 
tell us, represent cultural ideas about health 
and well-being and offer strategies to deal 
with illness. Medicines are good to think 
and to act with. Their concreteness puts 
structure upon the ‘untidy’ and uncertain 
experience of physical and mental suffering. 
Almost a decade later in 1996 both authors, 
together with medical anthropologist Anita 
Hardon, in an article for the periodical 
Annual Review of Anthropology, used the 
work of the Indian-American anthropolo-
gist Arjun Appadurai on the  ‘social life of 
things’  to introduce pharmaceu-
tical anthropology to their colleagues.5 In 
Commodities and the Politics of Value, the 
introduction of a volume of essays dealing 
with the social-cultural aspects of material 
objects, Appadurai argues that the value of 
material objects depend upon their social-
cultural context, at times called ‘arenas’ and 
‘sites’.6 He presents us with a moral econo-
my on things and argues that their meaning 
and therefore their value is culturally contin-
gent. Appadurai makes us aware that each 
arena is ruled by a ‘regime of value’ of its 
own. When we apply his ideas to medicines 
we see that these substances are subse-
quently tokens of modern technology, mer-
chandise, facilitators of clinical encounters 
and symbols of hope for the ill. 
Studies that highlight Asian medicine as a 
commercial activity and apply the insights 
of pharmaceutical anthropology to analyse 
their modernisation and commodification 
have been relatively scarce. This is surpris-
ing because the activities of manufacturers 
of Asian medicines determine, to a large 
extent, the image and substance of contem-
porary Asian medical traditions. In India, 
for example, the turnover of the Ayurvedic 
industry is twenty times higher than the 
money the government spends on all its 
medical traditions. Ayurvedic manufactur-
ers have a strong presence in Indian public 
life through their marketing efforts in the 
form of television commercials, omnipres-
ent signboards, sponsored articles on their 
medical products and companies, large fairs 
for promoting Indian medical products, and 
even beauty contests to market the skin 
products. The largest among the Ayurvedic 
manufacturers run their own medical col-
leges, research units, and publish maga-
zines aimed at different types of medical 
practitioners and the general public. How-
ever, in contrast to studies dealing with gov-
ernment policies and medical practice, the 
Asian indigenous medicine industry has not 
received the attention from social scientists 
that it deserves. Pharmaceutical Anthropol-
ogy offers a theoretical and methodological 
framework for those  who want to study 
the commercialisation, modernisation 
and transformation of Asian medical tradi-
tions such as Ayurveda, Traditional Chinese 
Medicine, Tibetan medicine, Jamu (Indone-
sia’s traditional medicine), traditional Thai 
medicine, as well as the commodification of 
the medical traditions of  Polynesia, South 
America and Africa. 
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Nowadays Ayurvedic medicines are mar-
keted as natural remedies against common 
discomforts such as indigestion, cough, 
muscle pain, headache, pimples and rashes, 
menstrual irregularities, whitish discharge, 
post partum and menopausal ailments. 
Increasingly, Ayurvedic medicines are pur-
chased by urban middle class consumers 
for the treatment of ‘modern’ ailments like 
diabetes, arthritis, Alzheimer’s and Parkin-
son’s disease, heart conditions, obesity, high 
cholesterol levels and high blood pressure. A 
variety of tonics, ‘to boost the immune sys-
tem’, is another important class of Ayurvedic 
medical products. 
2 Unani or Unani Tibb (literally ‘Greek medi-
cine’) is the term used in South Asia for 
Greek-Arabic medicine, a humoral pathology 
that is traced back to Hippocrates and Mus-
lim scholarship of the first millenium.
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The description of the centenary of the 
Ayurvedic manufacturer comes from my 
forthcoming book Taking Tradition Knowl-
edge to the Market: the Modern Image 
of the Ayurvedic and Unani Industry 
(Orient Longman 2008), which is based 
upon ethnographic research among 
large Ayurvedic and Unani manufactures 
in India during the period 1996-2002. 
In this book I look at two Indian medi-
cal traditions, Ayurveda and Unani Tibb 
through the lens of the Indian indigenous 
medical industry and their products, and 
highlight Indian medicine as a commer-
cial activity. As far as I am aware, Taking 
Tradition Knowledge to the Market is the 
first book that highlights Indian medicine 
as a commercial activity and applies the 
insights of pharmaceutical anthropol-
ogy to analyse the modernisation and 
commodification of traditional medical 
knowledge.
The seer in the test tube symbolises the coming 
together of tradition and modernity. The image 
is from a brochure of Zandu Pharmaceutical 
Works Ltd., one of the largest manufacturers of 
Ayurveda medicines. The brochure dates from 
the end of the 1980s or the beginning of the 
1990s.
